Stock Analysis

Metall Zug Full Year 2022 Earnings: Beats Expectations

SWX:METN
Source: Shutterstock
Advertisement

Metall Zug (VTX:METN) Full Year 2022 Results

Key Financial Results

  • Revenue: CHF645.9m (down 2.4% from FY 2021).
  • Net income: CHF130.0m (up 166% from FY 2021).
  • Profit margin: 20% (up from 7.4% in FY 2021). The increase in margin was driven by lower expenses.
  • EPS: CHF29.00.
earnings-and-revenue-history
SWX:METN Earnings and Revenue History March 16th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Metall Zug Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 5.7%.

The company's shares are down 9.6% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 1 warning sign for Metall Zug you should be aware of.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SWX:METN

Metall Zug

Through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, rest of Europe, the Americas, the Asia Pacific, and internationally.

Solid track record with adequate balance sheet.

Advertisement